HEMOSTASIS COAGULATION ROUTINE REAGENTS INHIBITOR NIJMEGEN BETHESDA ASSAYS FVIII INHIBITOR NIJMEGEN BETHESDA ASSAYS
CRYOcheck™ Factor VIII Inhibitor Kit
This kit, intended for use in the clinical laboratory, serves to standardize the preparation of samples for the assay of inhibitors by the modified Bethesda-Nijmegen method.
This kit is the ideal solution for laboratories wishing to use standardized sample preparations in order to limit the variability of anti-FVIII antibody assays.
Advantages
- Each kit contains five sets of vials, including positive and negative FVIII inhibitor controls
- Excellent repeatability and reproducibility
- Suitable for multicenter clinical studies
- Excellent linearity
- Convenient frozen format, ready to use in minutes, no reconstitution errors
Informations
Treatment for hemophilia A consists of injecting the missing Factor VIII by I.V. to prevent or stop the bleeding. A majority of the complications of this treatment are the development of antibodies against FVIII, called inhibitors.
The development of an anti-FVIII inhibitor leads to episodes of bleeding that are difficult to control.
The activity of the inhibitor is measured by a Bethesda test and is expressed in BU.
1BU neutralizes 50% of the activity of FVIII for hemophilia A.
Documentation
Download the product sheetPrice list, safety data sheets and notices are accessible to our registered customers.
Nijmegen Bethesda Assay
References
| CCIK08 | Kit | 10 tests |
